Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbusinesswire.com
Business Wire Health: Clinical Trials News
Get the latest updates from Business Wire Health: Clinical Trials News directly as they happen.
Follow now 107 followers
Latest posts
Last updated about 7 hours ago
Johnson & Johnson Announces a Proposed Resolution of Ovarian Talc Litigation
about 7 hours ago
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) (the "Company") today announced...
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Second Quarter 2026 Business and Financial Updates
about 9 hours ago
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated...
Secretome Therapeutics Expands Rare Disease Leadership Team
about 11 hours ago
PLANO, Texas--(BUSINESS WIRE)--Secretome Therapeutics, a clinical-stage biotechnology company developing novel therapies derived...
ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV
about 12 hours ago
LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK...
Feinstein Institutes Unveils World’s First Comprehensive Vagus Nerve Map, Substantiating Decades of Leadership in Bioelectronic Medicine
about 15 hours ago
MANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health’s Feinstein Institutes for Medical Research has announced the...
Massive Bio and GELL Announce Strategic Partnership to Advance Research, Medical Education, and Artificial Intelligence Across Latin America and the United States
about 15 hours ago
BOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio, a global leader in artificial intelligence-driven solutions...
LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board of Directors
about 15 hours ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--LAPIX Therapeutics has appointed Abbas Kazimi, Chief Executive Officer of...
Vasomune Therapeutics to Present on Pegevongitide Therapeutic Capability at the 2026 NATO NSPA CBRN
about 16 hours ago
TORONTO--(BUSINESS WIRE)-- #ARDS--CEO Dr. Brian Jahns presenting Pegevongitide (AV-001), Vasomune's dual-use drug...
Otsuka to Present Pivotal Two-Year eGFR Results from the Phase 3 VISIONARY Trial of VOYXACT® (sibeprenlimab-szsi) in IgA Nephropathy (IgAN) at GlomCon Hawaii 2026
about 17 hours ago
PRINCETON, N.J.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), announces that new...
Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery
about 18 hours ago
NEW YORK--(BUSINESS WIRE)---- $SDGR #BunsenAI--Schrödinger, Inc. today announced the launch of its...
Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia
about 18 hours ago
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it...
Enhanced Applauds FDA Advisory Committee's Landmark Vote to Expand Legal Compounding Pathway for Peptides
about 18 hours ago
NEW YORK--(BUSINESS WIRE)---- $ENHA #Enhanced--Enhanced Group Inc. (NYSE: ENHA) the elite sports...